News for Laurus Labs Limited (LAURUSLABS.BO)

Laurus Labs reports strong financial growth with increased revenue and profit, focusing on transformative progress and customer needs.

Drug firm Laurus Labs on Thursday said its consolidated profit increased three-fold to Rs 234 crore for the March quarter, driven by strong sales. The Hyderabad-based company reported a net profit of Rs 76 crore for the same quarter of FY24.

Stock market update: IndusInd, UltraTech, Grasim, Trent, Dr Reddy’s gain; HUL, M&M, Bharti Airtel, ICICI Bank, ONGC decline.

The Nifty Pharma index was trading 1.27 per cent up at 22014.35.

The Nifty Pharma index closed 1.4 per cent up at 21738.95.

Top gainers, losers today April 23, 2025: Sectoral indices showed mixed movement, with bank stocks facing the maximum selling pressure.

The Nifty Pharma index closed 0.41 per cent up at 21438.05.

The Nifty Pharma index was trading 0.5 per cent up at 21458.35.

Amidst market volatility, high beta stocks experienced steeper declines, with many falling significantly from their peaks. Low beta stocks demonstrated greater resilience, declining less on average. Factors like global trade tensions, FII selling, and concerns over corporate earnings have contributed to market wobbles. However, recent FII buying and expectations of India's economic outperformance offer some tailwinds.

Despite a stellar rally today , both Nifty midcap and smallcap indices are down 17% and 12%, respectively this year.

The Nifty Pharma index was trading 1.78 per cent down at 20015.95.

The Nifty Pharma index closed 1.91 per cent up at 20377.9.

The Nifty Pharma index was trading 1.24 per cent up at 20243.4.

Global stock markets plunged after President Trump announced a 10% blanket tariff on all U.S. trading partners, with higher rates for surplus countries like India at 26%. This triggered fears of a trade war and recession, impacting the Indian Sensex and Nifty50, and hitting sectors like metals, pharma, and IT hard.

Sensex tanks 800 pts, Nifty 50 trades below 23,000 level. Bajaj Finance & HDFC Bank lead gainers. ONGC, Hindalco, Tata Motors and Cipla drag

Granules India, Lupin, Gland Pharma and Cipla fell 5-6 per cent. Sun Pharmaceutical Industries slipped 5 per cent while Dr Reddy's Labs was down 4 per cent.

Stock Market Crash Today: Indian stock markets experienced a sharp drop as renewed recession fears and President Trump's new tariff announcements sparked a global selloff. The Sensex fell 836 points, with broad-based selling pulling down sectoral indices including metal, pharma, and IT. Investor sentiment was affected by potential tariffs targeting the pharma sector and heightened global uncertainty.

The Nifty Pharma index closed 0.87 per cent up at 20952.85.

The Nifty Pharma index was trading 0.29 per cent down at 21076.2.